Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis b cirrhosis 14 years after primary liver transplantation

被引：24

作者：

Kita, Yoshiaki

Klintmalm, Goean

Kobayashi, Susumu

Yanaga, Katsuhiko

机构：

[1] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058471, Japan

[2] Baylor Univ, Med Ctr, Baylor Reg Transplant Inst, Dallas, TX USA

来源：

DIGESTIVE DISEASES AND SCIENCES | 2007年 / 52卷 / 12期

关键词：

Tace; Lamivudine; Orthotopic Liver Transplantation; Transcatheter Arterial Chemoembolization; Portal Vein Invasion;

D O I：

10.1007/s10620-006-9574-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：3392 / 3393

页数：2

共 3 条

[1] Donor origin of de novo hepatocellular carcinoma in hepatic allografts [J].

Flemming, P ;

Tillmann, HL ;

Barg-Hock, H ;

Kleeberger, W ;

Manns, MP ;

Klempnauer, J ;

Kreipe, HH .

TRANSPLANTATION, 2003, 76 (05) :871-873

[2] De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis [J].

Saxena, R ;

Ye, MQ ;

Emre, S ;

Klion, F ;

Nalesnik, MA ;

Thung, SN .

LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (01) :81-82

[3] ORTHOTOPIC LIVER-TRANSPLANTATION FOR PATIENTS WITH HEPATITIS-B VIRUS RELATED LIVER-DISEASE [J].

TODO, S ;

DEMETRIS, AJ ;

VANTHIEL, D ;

TEPERMAN, L ;

FUNG, JJ ;

STARZL, TE .

HEPATOLOGY, 1991, 13 (04) :619-626

← 1 →